AI assistant
Sending…
Glenmark Pharmaceuticals ltd — Remuneration Information 2019
Jul 1, 2019
62608_rns_2019-07-01_1ceb19f8-a1d7-480a-9946-d61431056137.pdf
Remuneration Information
Open in viewerOpens in your device viewer
==> picture [131 x 63] intentionally omitted <==
==> picture [7 x 165] intentionally omitted <==
==> picture [7 x 105] intentionally omitted <==
==> picture [6 x 68] intentionally omitted <==
| Glenmark FoundationGlenmark Aquatic Foundation | |
|---|---|
| Trilegal | |
| RsInmillion | |
| NatureofTransaction | Yearended |
| 31March 2019 | |
| Purchaseofservices | |
| Trilegal | 24.59 |
| ExpenditureincurredforCSRactivitiesto | |
| Glenmark Foundation | 141.76 |
| Glen mark Aquatic Foundation | 64.00 |
| Transactionswithkeymanagementpersonnel | |
| Remuneration | |
| -Mr.Glenn Saldanha | 157.05 |
| - Mrs. Charylann Pinto | 42.92 |
| -MrVSMani | 45.6 |
| -MrMurali Neelakantan (Relatedpartyasper companies Act,2013tillMay29, 2018) | 43.07 |
| -Mr.Harish Kuber | 3.27 |
| - Ms. Ruchita Gandhi (Relatedpartyaspercompanies Act,2013witheffectfromJanuary 1, | |
| 2019) | 1.66 |
| Sitting fees paidtoNOA-executive Directors | 8.3 |
==> picture [5 x 147] intentionally omitted <==
==> picture [83 x 85] intentionally omitted <==
More from Glenmark Pharmaceuticals ltd
Investor Presentation
2026
May 29
Investor Presentation
2026
May 29
Earnings Release
2026
May 29
Earnings Release
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 29
Board/Management Information
2026
May 29
Interim / Quarterly Report
2026
May 29